Kestra Medical Technologies, Ltd. Common Stock earnings per share and revenue
On Mar 17, 2026, KMTS reported earnings of -0.61 USD per share (EPS) for Q3 26, missing the estimate of -0.60 USD, resulting in a -0.39% surprise. Revenue reached 24.55 million, compared to an expected 23.32 million, with a 5.29% difference. The market reacted with a -7.38% price change (close before vs. close after earnings).
Looking ahead to -- --, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Capricor Therapeutics Inc
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.55
Actual
-$0.62
Surprise
-12.56%
Sundial Growers Inc. Common Shares
Report Date
Mar 12, 2026 For Q4 25
Estimate
-$0.01
Actual
$0.04
Surprise
+499.62%
High Tide Inc. Common Shares
Report Date
Mar 17, 2026 For Q1 26
Estimate
$0.00
Actual
$0.01
Surprise
+447.68%
Sanara MedTech Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
$0.11
Actual
$0.04
Surprise
-64.35%
Cytosorbents Corp.
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.09
Surprise
-76.47%
Nephros Inc.
Report Date
Mar 12, 2026 For Q4 25
Estimate
$0.01
Actual
$0.08
Surprise
+684.31%
FAQ
What were Kestra Medical Technologies, Ltd. Common Stock's earnings and revenue for the latest quarter Q3 2026?
For Q3 2026, Kestra Medical Technologies, Ltd. Common Stock reported EPS of -$0.61, missing estimates by -0.39%, and revenue of $24.55M, 5.29% above expectations.
How did the market react to Kestra Medical Technologies, Ltd. Common Stock's Q3 2026 earnings?
The stock price moved down -7.38%, changed from $21.14 before the earnings release to $19.58 the day after.
When is Kestra Medical Technologies, Ltd. Common Stock expected to report next?
The next earning report is scheduled for --.
What are the forecasts for Kestra Medical Technologies, Ltd. Common Stock's next earnings report?
Based on --
analysts, Kestra Medical Technologies, Ltd. Common Stock is expected to report EPS of -- and revenue of -- for Q-- --.